These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34905269)

  • 21. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
    Sakuraba A; Luna A; Micic D
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
    Liew J; Gianfrancesco M; Harrison C; Izadi Z; Rush S; Lawson-Tovey S; Jacobsohn L; Ja C; Hyrich KL; Gossec L; Strangfeld A; Carmona L; Schäfer M; Frãzao-Mateus E; Bulina I; Stafford F; Tufan A; Graver C; Yardımcı GK; Zepa J; Al Emadi S; Cook C; Abutiban F; Dey D; Katigbak G; Kaufman L; Kowalski E; Martínez-Martínez MU; Patel NJ; Reyes-Cordero G; Salido E; Smith E; Snow D; Sparks J; Wise L; Bhana S; Gore-Massy M; Grainger R; Hausmann J; Sirotich E; Sufka P; Wallace Z; Machado PM; Robinson PC; Yazdany J
    RMD Open; 2022 Apr; 8(1):. PubMed ID: 35387864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of Severe SARS-CoV-2 Infection in Fully Vaccinated Solid Organ Transplant Recipients.
    Marinaki S; Xagas E; Tsoutsoura P; Katsaros D; Korogiannou M; Boletis IN
    Transplant Proc; 2022; 54(6):1405-1408. PubMed ID: 35074163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY.
    ; Green A; Curtis H; Hulme W; Williamson E; McDonald H; Bhaskaran K; Rentsch C; Schultze A; MacKenna B; Mahalingasivam V; Tomlinson L; Walker A; Fisher L; Massey J; Andrews C; Hopcroft L; Morton C; Croker R; Morley J; Mehrkar A; Bacon S; Evans D; Inglesby P; Hickman G; Ward T; Davy S; Mathur R; Tazare J; Eggo R; Wing K; Wong A; Forbes H; Bates C; Cockburn J; Parry J; Hester F; Harper S; Douglas I; Evans S; Smeeth L; Goldacre B
    BMC Med; 2022 Jul; 20(1):243. PubMed ID: 35791013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
    Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
    JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severity of SARS-CoV-2 infection among vaccinated individuals: A hospital-based study.
    Govindapala D; Jayasekara P; Rajramanan R; de Silva N
    Ceylon Med J; 2022 Dec; 67(4):143-150. PubMed ID: 38421276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave.
    Solera JT; Árbol BG; Bahinskaya I; Marks N; Humar A; Kumar D
    Am J Transplant; 2023 Jan; 23(1):78-83. PubMed ID: 36148607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.
    Naylor KL; Kim SJ; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Knoll GA
    Am J Transplant; 2022 Sep; 22(9):2228-2236. PubMed ID: 35578576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethical considerations regarding COVID-19 vaccination for transplant candidates and recipients.
    Parent B; Caplan A; Mehta SA
    Clin Transplant; 2021 Oct; 35(10):e14421. PubMed ID: 34241923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
    Hedvat J; Lange NW; Salerno DM; DeFilippis EM; Kovac D; Corbo H; Chen JK; Choe JY; Lee JH; Anamisis A; Jennings DL; Codispodo G; Shertel T; Brown RS; Pereira MR
    Am J Transplant; 2022 Nov; 22(11):2682-2688. PubMed ID: 35801839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
    Malinis M; Cohen E; Azar MM
    Am J Transplant; 2021 Aug; 21(8):2916-2918. PubMed ID: 34101990
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.
    Karruli A; Spiezia S; Boccia F; Gagliardi M; Patauner F; Salemme A; Maiello C; Zampino R; Durante-Mangoni E
    Transpl Infect Dis; 2021 Aug; 23(4):e13595. PubMed ID: 33641202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Review of Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination Following Solid Organ Transplantation.
    Cieślak I; Kwapisz M; Tronina O; Gotlib J; Lisik W; Wasiak D; Hreńczuk M; Rahnama M; Małkowski P
    Ann Transplant; 2022 Sep; 27():e936949. PubMed ID: 36110033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
    Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
    Front Immunol; 2022; 13():906225. PubMed ID: 35720376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
    Sandoval M; Nguyen DT; Huang HJ; Yi SG; Ghobrial RM; Gaber AO; Graviss EA
    PLoS One; 2022; 17(12):e0279222. PubMed ID: 36542654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls.
    Vinson AJ; Anzalone AJ; Sun J; Dai R; Agarwal G; Lee SB; French E; Olex A; Ison MG; Mannon RB;
    Am J Transplant; 2022 Oct; 22(10):2418-2432. PubMed ID: 35674237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City.
    Tsapepas D; Husain SA; King KL; Burgos Y; Cohen DJ; Mohan S
    Am J Health Syst Pharm; 2021 Nov; 78(22):2040-2045. PubMed ID: 34185824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
    Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
    Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.